
IDEXX Raises 2026 EPS Outlook Following Double-Digit Second-Quarter Revenue Growth
IDEXX Laboratories reported second-quarter 2026 revenue of $1.22 billion, driven by continued growth in companion animal diagnostics, and increased its full-year earnings outlook while modestly raising its revenue guidance. A summary of the company’s financial performance is below. The complete earnings report is available at https://www.idexx.com/investors/.
